tradingkey.logo

MaxCyte Inc <MXCT.OQ> expected to post a loss of 10 cents a share - Earnings Preview

ReutersAug 4, 2025 8:09 PM
  • MaxCyte Inc MXCT.OQ MXCT.O is expected to show a fall in quarterly revenue when it reports results on August 6 for the period ending June 30 2025

  • The Rockville Maryland-based company is expected to report a 8.6% decrease in revenue to $9.528 million from $10.43 million a year ago, according to the mean estimate from 6 analysts, based on LSEG data.

  • ​LSEG's mean analyst estimate for MaxCyte Inc is for a loss of 10 cents per share.

  • The current average analyst rating on the shares is "strong buy" and the breakdown of recommendations is 6 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."

  • The mean earnings estimate of analysts had risen by about 4.5% in the last three months. ​

  • Wall Street's median 12-month price target for MaxCyte Inc is $6.50, about 68.6% above its last closing price of $2.04

Previous quarterly performance (using preferred earnings measure in US dollars). ​

QUARTER ENDING

STARMINESMARTESTIMATE®

LSEG IBES ESTIMATE

ACTUAL

BEAT, MET, MISSED

SURPRISE %

Mar. 31 2025

-0.11

-0.10

-0.10

Met

4.8

Dec. 31 2025

-0.11

-0.12

-0.10

Beat

18

Sep. 30 2024

-0.12

-0.12

-0.11

Beat

10.8​

Jun. 30 2024

-0.13

-0.13

-0.09

Beat

28.9

​​Mar. 31 2024

-0.13

-0.13

-0.09

Beat

30.8

Dec. 31 2023

-0.07

-0.07

-0.05

Beat

30.6​

Sep. 30 2023

-0.10

-0.10

-0.11

Missed

-7.8

Jun. 30 2023

-0.10

-0.10

-0.10

Met

-4.2

This summary was machine generated August 4 at 20:09 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI